
Abdelmoniem I. Elamin
Examiner (ID: 12006, Phone: (571)272-3674 , Office: P/2116 )
| Most Active Art Unit | 2116 |
| Art Unit(s) | 2782, 2182, 2116, 2115 |
| Total Applications | 1536 |
| Issued Applications | 1371 |
| Pending Applications | 36 |
| Abandoned Applications | 132 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 1219710
[patent_doc_number] => 06703031
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-09
[patent_title] => 'Cysteine derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/806937
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9139
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 413
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703031.pdf
[firstpage_image] =>[orig_patent_app_number] => 09806937
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/806937 | Cysteine derivatives | Jun 13, 2001 | Issued |
Array
(
[id] => 6308299
[patent_doc_number] => 20020095050
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-18
[patent_title] => 'Phenylserine derivatives as integrin antagonists'
[patent_app_type] => new
[patent_app_number] => 09/879483
[patent_app_country] => US
[patent_app_date] => 2001-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6902
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20020095050.pdf
[firstpage_image] =>[orig_patent_app_number] => 09879483
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/879483 | Phenylserine derivatives as integrin antagonists | Jun 11, 2001 | Issued |
Array
(
[id] => 6598136
[patent_doc_number] => 20020042379
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-11
[patent_title] => 'Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion'
[patent_app_type] => new
[patent_app_number] => 09/879718
[patent_app_country] => US
[patent_app_date] => 2001-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2156
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20020042379.pdf
[firstpage_image] =>[orig_patent_app_number] => 09879718
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/879718 | Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion | Jun 10, 2001 | Abandoned |
Array
(
[id] => 1343307
[patent_doc_number] => 06586468
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => '-substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient'
[patent_app_type] => B1
[patent_app_number] => 09/787087
[patent_app_country] => US
[patent_app_date] => 2001-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19540
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 307
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586468.pdf
[firstpage_image] =>[orig_patent_app_number] => 09787087
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/787087 | -substituted phenyl-prostaglandin E derivatives and drugs containing the same as the active ingredient | Jun 10, 2001 | Issued |
Array
(
[id] => 6363159
[patent_doc_number] => 20020058834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-16
[patent_title] => 'Preparation of N-acyl amino carboxylic acids, amino carboxylic acids and their derivatives by metal-catalyzed carboxymethylation in the presence of a promoter'
[patent_app_type] => new
[patent_app_number] => 09/871869
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22043
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20020058834.pdf
[firstpage_image] =>[orig_patent_app_number] => 09871869
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/871869 | Preparation of N-acyl amino carboxylic acids, amino carboxylic acids and their derivatives by metal-catalyzed carboxymethylation in the presence of a promoter | May 31, 2001 | Abandoned |
Array
(
[id] => 1400577
[patent_doc_number] => 06541663
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-04-01
[patent_title] => 'Process for preparation of aminocarboxylic acids'
[patent_app_type] => B2
[patent_app_number] => 09/872653
[patent_app_country] => US
[patent_app_date] => 2001-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3531
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541663.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872653
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872653 | Process for preparation of aminocarboxylic acids | May 31, 2001 | Issued |
Array
(
[id] => 1528499
[patent_doc_number] => 06479548
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-12
[patent_title] => 'Substituted stilbenes as glucose uptake enhancers'
[patent_app_type] => B2
[patent_app_number] => 09/872763
[patent_app_country] => US
[patent_app_date] => 2001-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12071
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479548.pdf
[firstpage_image] =>[orig_patent_app_number] => 09872763
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/872763 | Substituted stilbenes as glucose uptake enhancers | May 30, 2001 | Issued |
Array
(
[id] => 680120
[patent_doc_number] => 07084136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-08-01
[patent_title] => 'Drug composition antagonistic to both PGD2/TXA2 receptors'
[patent_app_type] => utility
[patent_app_number] => 10/297065
[patent_app_country] => US
[patent_app_date] => 2001-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 119868
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/084/07084136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10297065
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/297065 | Drug composition antagonistic to both PGD2/TXA2 receptors | May 27, 2001 | Issued |
Array
(
[id] => 1329452
[patent_doc_number] => 06600060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-29
[patent_title] => 'CLA-esters'
[patent_app_type] => B2
[patent_app_number] => 09/864881
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2358
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/600/06600060.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864881
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864881 | CLA-esters | May 24, 2001 | Issued |
Array
(
[id] => 758671
[patent_doc_number] => 07015351
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-21
[patent_title] => 'Reaction systems for making N-(phosphonomethyl) glycine compounds'
[patent_app_type] => utility
[patent_app_number] => 09/863885
[patent_app_country] => US
[patent_app_date] => 2001-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 83529
[patent_no_of_claims] => 249
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/015/07015351.pdf
[firstpage_image] =>[orig_patent_app_number] => 09863885
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/863885 | Reaction systems for making N-(phosphonomethyl) glycine compounds | May 21, 2001 | Issued |
Array
(
[id] => 1575837
[patent_doc_number] => 06469183
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Method of producing phthalic acid anhydride'
[patent_app_type] => B1
[patent_app_number] => 09/856292
[patent_app_country] => US
[patent_app_date] => 2001-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2022
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469183.pdf
[firstpage_image] =>[orig_patent_app_number] => 09856292
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/856292 | Method of producing phthalic acid anhydride | May 20, 2001 | Issued |
Array
(
[id] => 6034213
[patent_doc_number] => 20020019557
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Synthesis of N-[N-(3,3-dimethylbutyl)-L-alpha-aspartyl]-L-phenylalanine 1-methyl ester using L-alpha-aspartyl-L- phenylalanine 1-methyl ester precursors'
[patent_app_type] => new
[patent_app_number] => 09/859438
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4705
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019557.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859438
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859438 | Synthesis of N-N-(3,3-dimethylbutyl)-L--aspartyl-L-phenylalanine 1-methyl ester using L--aspartyl-L-phenylalanine 1-methyl ester precursors | May 17, 2001 | Issued |
Array
(
[id] => 5889693
[patent_doc_number] => 20020013490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'Synthesis of N- [N-(3,3-dimethylbutyl)-L-alpha-aspartyl] -L-phenylalantine 1-methyl ester using oxazolidinone derivatives'
[patent_app_type] => new
[patent_app_number] => 09/859439
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013490.pdf
[firstpage_image] =>[orig_patent_app_number] => 09859439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/859439 | Synthesis of N-[N-(3,3-dimethylbutyl)-L-α-aspartyl]-L-phenylalanine 1-methyl ester using oxazolidinone derivatives | May 17, 2001 | Issued |
Array
(
[id] => 1151617
[patent_doc_number] => 06770775
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-08-03
[patent_title] => 'Method of synthesizing optically enriched -halo-esters, and product and composition therefrom'
[patent_app_type] => B2
[patent_app_number] => 09/861221
[patent_app_country] => US
[patent_app_date] => 2001-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 5731
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/770/06770775.pdf
[firstpage_image] =>[orig_patent_app_number] => 09861221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/861221 | Method of synthesizing optically enriched -halo-esters, and product and composition therefrom | May 17, 2001 | Issued |
Array
(
[id] => 6142319
[patent_doc_number] => 20020002202
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-03
[patent_title] => 'Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia'
[patent_app_type] => new
[patent_app_number] => 09/858639
[patent_app_country] => US
[patent_app_date] => 2001-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3082
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0002/20020002202.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858639
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858639 | Use of fumarate salt of L-carnitine or its alkanoyl derivatives in ischaemia | May 16, 2001 | Abandoned |
Array
(
[id] => 6913228
[patent_doc_number] => 20050176986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-08-11
[patent_title] => 'Catalyst for esterification and transesterification and process for producing ester'
[patent_app_type] => utility
[patent_app_number] => 10/275758
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19644
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20050176986.pdf
[firstpage_image] =>[orig_patent_app_number] => 10275758
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/275758 | Catalyst for esterification and transesterification and process for producing ester | May 14, 2001 | Issued |
Array
(
[id] => 6034257
[patent_doc_number] => 20020019565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Process for making iminodiacetic acid compounds from monoethanolamine substrates'
[patent_app_type] => new
[patent_app_number] => 09/858117
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 23002
[patent_no_of_claims] => 191
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019565.pdf
[firstpage_image] =>[orig_patent_app_number] => 09858117
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/858117 | Process for making iminodiacetic acid compounds from monoethanolamine substrates | May 14, 2001 | Issued |
Array
(
[id] => 7079418
[patent_doc_number] => 20010041812
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-15
[patent_title] => 'Process for the preparation of N-carboxy-t-leucine anhydride'
[patent_app_type] => new
[patent_app_number] => 09/852849
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1191
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20010041812.pdf
[firstpage_image] =>[orig_patent_app_number] => 09852849
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/852849 | Process for the preparation of N-carboxy-t-leucine anhydride | May 10, 2001 | Issued |
Array
(
[id] => 1120465
[patent_doc_number] => 06797842
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-09-28
[patent_title] => 'Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same'
[patent_app_type] => B2
[patent_app_number] => 09/853085
[patent_app_country] => US
[patent_app_date] => 2001-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17620
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/797/06797842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09853085
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/853085 | Process for producing optically active 1-(fluoro- or trifluoromethyl-substituted phenyl) ethylamine and process for purifying same | May 10, 2001 | Issued |
Array
(
[id] => 1491357
[patent_doc_number] => 06417388
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-09
[patent_title] => 'Method for producing alkenyl-substituted bis(oxime ether) derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/831412
[patent_app_country] => US
[patent_app_date] => 2001-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3795
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/417/06417388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09831412
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/831412 | Method for producing alkenyl-substituted bis(oxime ether) derivatives | May 8, 2001 | Issued |